3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
44
Colonic Neoplasms
17
Colonic Polyps
12
Adenoma
8
Polyps
4
Gastrointestinal Neoplasms
3
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Adenomatous Polyps
3
Rectal Neoplasms
2
Neoplasms
2
Intestinal Neoplasms
2
Stomach Neoplasms
1
Rectal Diseases
1
Peptic Ulcer
1
Patient Satisfaction
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Metabolic Syndrome
1
Liver Cirrhosis
1
Irritable Bowel Syndrome
1
Intestinal Diseases
1
Hyperplasia
1
Gastrointestinal Hemorrhage
1
Gastrointestinal Diseases
1
Gastritis, Atrophic
1
Diverticulitis, Colonic
1
Diverticulitis
1
Disease
1
Interventions
alvimopan
5
Surveys and Questionnaires
2
Cyclophosphamide
2
pralsetinib
1
pembrolizumab
1
napabucasin
1
guadecitabine
1
Ursodeoxycholic Acid
1
Surgical Procedures, Operative
1
Pemetrexed
1
Oxaliplatin
1
Oviposition
1
Ocoxin
1
Low Density Lipoprotein Receptor-Related Protein-1
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Exercise
1
Drainage
1
Colonoscopy
1
Cetuximab
1
Celecoxib
1
Capecitabine
1
Calcium Dobesilate
1
Bupivacaine
1
Bevacizumab
1
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide
1
5,10-methylenetetrahydrofolic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Intestinal Diseases
×
Colonoscopy
×
Clear all
NCT04287335
2020-12-08
CLEAR-C
Zhejiang University
Completed
4,758 enrolled